Entrada Therapeutics, Inc. · NASDAQ:TRDA

Dowden Nathan J sold 15,000 Entrada Therapeutics, Inc. shares (Form 4)

Traded May 4, 2026 · Filed May 4, 2026

On May 4, 2026, Dowden Nathan J (President & COO) sold 15,000 Entrada Therapeutics, Inc. shares at US$15.33 for US$230K under a trading plan, leaving 198,588 shares. Filed May 4, 2026 (Form 4).

Sold
15,000 shares
Price
US$15.33
Value
US$230K
Holding after
198,588 shares
Trading plan
Yes (Made under a plan set in advance)
Role
President & COO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
May 4, 2026Common StockOption exercise15,000US$1.74213,588Direct
May 4, 2026Common StockSale15,000US$15.33198,588Direct

Source

View original at SEC

Related